TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Cellino has launched Reservoir, a service that collects and cryopreserves adults’ immune cells for possible future medical use. It typically costs about $5,000 for collection, processing and the first year of storage, followed by $270 annually; whether banking cells benefits healthy consumers is not established.
Biotech company Cellino has launched Reservoir, a consumer service that collects and cryopreserves immune cells from adults for possible future medical use. The service typically starts at about $5,000, including the first year of storage, then costs $270 annually; the potential benefit for healthy people remains uncertain.
Reservoir begins with a standard blood draw at a partner clinic or, in select markets, through an at-home appointment. Cellino says it isolates peripheral blood mononuclear cells, or PBMCs, which include T cells, B cells, natural killer cells and monocytes. The cells are counted, cryopreserved and stored at temperatures below -150°C in an FDA-registered facility, according to the company.
The company says the typical starting price is about $5,000, though costs vary by clinic. That amount covers collection, processing, cryopreservation and the first storage year; continued storage costs $270 per year. The service is open to adults 18 and older. Cellino says members own their stored cells, which are released only at the member’s request and in coordination with a licensed physician.
Reservoir is initially offered through partner clinics in markets including San Francisco, Los Angeles, New York and Boston. At-home collection is available in some locations, and Cellino says it plans to add markets. Consumers can check availability or join a nationwide waitlist through Reservoir’s website.
A Costly Bet on Future Cell Therapies
The launch gives consumers a way to store their own immune cells outside research settings or specific medical procedures. Cellino is selling the service as a way to retain future options as cell-based medicine develops, not as a treatment or a demonstrated way to extend life. That distinction matters: customers pay thousands of dollars now without a defined future use or a guarantee that stored cells will be suitable for a later therapy.
For prospective customers, the practical trade-off is between the present cost and the possibility that future medicine could use the stored material. That possibility has not been established as a health benefit for otherwise healthy adults. The annual fee also means the total cost grows with the length of storage, while the timing, availability and price of any future use are not specified in the report.
The service also extends Cellino’s work from technology for manufacturing personalized cell therapies into a direct-to-consumer offering. The company is asking people to invest in preserving biological material ahead of medical advances, even though the clinical value of doing so remains unclear.
As an affiliate, we earn on qualifying purchases.
From Cellino’s Lab to Consumer Storage
Cellino, based in Cambridge, Massachusetts, was co-founded in 2017 by Nabiha Saklayen and Marinna Madrid after they conducted research at Harvard. The company is developing automated manufacturing technology intended to help produce personalized cell therapies at scale. The original report says Cellino has raised more than $96 million from investors and received an award of up to $25 million from the Advanced Research Projects Agency for Health, as well as an FDA Advanced Manufacturing Technology designation for its platform.
Cellino says requests from people who learned about its work helped prompt Reservoir’s development. The company likens cell banking to egg freezing and cord blood banking, but the future applications of stored immune cells are less defined. Cryopreservation is used in research and medical settings; that fact alone does not establish that preventive storage will benefit healthy customers.
““Cell preservation is unique because it is fundamentally about optionality: preserving your cells as they are today, so that whatever the science makes possible later, you still have the material to use.””
— Jay Luthar, Harvard Medical School faculty member and founder of partner clinic Lutanen Health, as quoted by Athletech News
cryopreservation blood collection kit
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Future Uses Remain Unproven
The report does not identify a specific approved treatment that Reservoir customers can access using their stored cells, or evidence that banking immune cells improves health outcomes for healthy adults. It also does not describe how likely stored cells are to be usable in future therapies, what additional processing or treatment might cost, or what happens if a customer’s cells cannot be used.
Cellino says the cells are stored in an FDA-registered facility, but that description should not be read as FDA approval of Reservoir as a longevity treatment. Clinical utility, future access and total long-term cost remain open questions. The report also does not provide details on storage duration guarantees or what arrangements apply if a customer stops paying the annual fee.
personal immune cell storage container
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Market Rollout and Customer Terms
Cellino says it plans to expand Reservoir beyond its initial partner-clinic markets, while at-home collection remains limited to select locations. The company directs prospective customers to its website to check local availability or join a nationwide waitlist. Further market additions are planned, but the report gives no timetable.
As the service reaches more consumers, details that may shape decisions include clinic-specific pricing, storage terms and the process and costs for requesting cells. Any future claims about medical use will need to be evaluated against clinical evidence and applicable regulatory decisions; the launch itself does not establish that those uses will become available.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is Cellino’s Reservoir service?
Reservoir is a cell-banking service that collects immune cells from a blood sample, processes and cryopreserves them, then stores them for possible future medical use.
How much does immune cell banking cost?
The service typically starts at about $5,000, covering collection, processing, freezing and the first year of storage. Cellino lists an annual storage fee of $270 after that, with prices varying by clinic.
Can customers use the stored cells for a treatment now?
The report does not identify a specific current treatment available to Reservoir customers using their stored cells. Potential future uses remain uncertain, and the service is not presented as a proven longevity treatment.
Where is Reservoir available?
Cellino says the service is initially offered through partner clinics in San Francisco, Los Angeles, New York and Boston, with at-home collection in select locations. The company says additional markets are planned.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
